TY  - JOUR
AU  - Martin-Broto, Javier
AU  - Hindi, Nadia
AU  - Grignani, Giovanni
AU  - Martinez-Trufero, Javier
AU  - Redondo, Andres
AU  - Valverde, Claudia
AU  - Stacchiotti, Silvia
AU  - Lopez-Pousa, Antonio
AU  - D'Ambrosio, Lorenzo
AU  - Gutierrez, Antonio
AU  - Perez-Vega, Herminia
AU  - Encinas-Tobajas, Victor
AU  - de Alava, Enrique
AU  - Collini, Paola
AU  - Peña-Chilet, Maria
AU  - Dopazo, Joaquin
AU  - Carrasco-Garcia, Irene
AU  - Lopez-Alvarez, Maria
AU  - Moura, David S
AU  - Lopez-Martin, Jose A
PY  - 2020
DO  - 10.1136/jitc-2020-001561
UR  - http://hdl.handle.net/10668/16624
T2  - Journal for immunotherapy of cancer
AB  - Sarcomas exhibit low expression of factors related to immune response, which could explain the modest activity of PD-1 inhibitors. A potential strategy to convert a cold into an inflamed microenvironment lies on a combination therapy. As tumor...
LA  - en
PB  - BMJ Group
KW  - clinical trials as topic
KW  - immunotherapy
KW  - sarcoma
KW  - translational medical research
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents, Immunological
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Nivolumab
KW  - Sarcoma
KW  - Sunitinib
KW  - Young Adult
TI  - Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial.
TY  - research article
VL  - 8
ER  -